PARP inhibitors are novel therapies with indication focused on ovarian cancer; however, new agents are being studied for other cancers as well.
Michelle Shahbol, PharmD
Advertisement
Articles by Michelle Shahbol, PharmD
As the industry focuses more on value-based care, predictive modeling allows pharmacies to shift their services from a one-size-fits-all approach to a personalized, high-touch strategy.
Advertisement
Latest Updated Articles
A Predictive Modeling Primer for Specialty PharmacyPublished: February 5th 2020 | Updated:
PARP Inhibitors: A Novel Approach to Treating Ovarian CancerPublished: March 2nd 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Announces Recall 580,000 Bottles of Prazosin Over Potential Carcinogenic Impurity
2
Regular Melatonin Supplementation May Hide Hidden Heart Complications
3
COVID-19 During Pregnancy Raises Neurodevelopmental Risks in Children
4
From Type 1 to Type 2 and Beyond: Navigating the Landscape of Diabetes
5
